These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 684055)

  • 1. Studies on the identification of 1.4-benzodiazepine drugs by micro-crystal tests.
    Tewari SN; Shukla SK
    Pharmazie; 1978 Jun; 33(6):372-3. PubMed ID: 684055
    [No Abstract]   [Full Text] [Related]  

  • 2. A contribution to the pharmaceutical analysis of benzodiazepines.
    Sánchez-Moyano E; Herráez M; Plá-Delfina JM
    Pharm Acta Helv; 1986; 61(5-6):167-76. PubMed ID: 3725818
    [No Abstract]   [Full Text] [Related]  

  • 3. A new universal high-performance liquid chromatographic method for determination of 1,4-benzodiazepines as bulk drugs and in pharmaceutical formulations.
    Kazemifard AG; Javadzadeh N; Gholami K
    Acta Pol Pharm; 2008; 65(2):179-86. PubMed ID: 18666423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro study of the partition of drugs in triphasic systems. III. Partition of various benzodiazepines in triphasic water/oil/water systems].
    Rodriguez L; Chiarini A; Zecchi V
    Farmaco Prat; 1981 Jun; 36(6):304-11. PubMed ID: 7274411
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of cocrystals in pharmaceutical science.
    Shan N; Zaworotko MJ
    Drug Discov Today; 2008 May; 13(9-10):440-6. PubMed ID: 18468562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of benzodiazepine-like activity in hepatic encephalopathy requires an initial lipophilic extraction procedure!
    Gacad R; Kaminsky-Russ K; Mullen KD
    Hepatology; 1994 Aug; 20(2):544-6. PubMed ID: 8045518
    [No Abstract]   [Full Text] [Related]  

  • 7. Spectrophotometric determination of some 1,4-benzodiazepines by use of orthogonal polynomials.
    el-Yazbi FA; Abdel-Hay MH; Korany MA
    Pharmazie; 1986 Sep; 41(9):639-42. PubMed ID: 2879294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the scope of crystal form evaluation in pharmaceutical science.
    Peterson ML; Hickey MB; Zaworotko MJ; Almarsson O
    J Pharm Pharm Sci; 2006; 9(3):317-26. PubMed ID: 17207415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of surface ionization methods for highly sensitive and selective analysis of benzodiazepine derivatives.
    Khasanov U; Rasulev U; Usmanov D; Iskhakova S; Nabiev U
    J Pharm Biomed Anal; 2005 Apr; 37(5):1125-33. PubMed ID: 15862696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting and controlling API crystal form for pharmaceutical development--strategies and processes.
    Yin SX; Grosso JA
    Curr Opin Drug Discov Devel; 2008 Nov; 11(6):771-7. PubMed ID: 18946842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical evaluation of the application of capillary electrophoresis to the detection and determination of 1,4-benzodiazepine tranquilizers in formulations and body materials.
    Smyth WF; McClean S
    Electrophoresis; 1998 Nov; 19(16-17):2870-82. PubMed ID: 9870382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gas-liquid chromatography with Fourier-transform infrared spectrophotometry. Application in the analysis of drugs. 2: Benzodiazepines].
    Rollmann B; Tilquin B
    J Pharm Belg; 1991; 46(6):357-62. PubMed ID: 1783969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of vitreous humor as an alternative to whole blood for the analysis of benzodiazepines.
    Scott KS; Oliver JS
    J Forensic Sci; 2001 May; 46(3):694-7. PubMed ID: 11373010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N; de Matas M; Gavan PT; York P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thin layer chromatographic technique for the separation and identification of 1.4-benzodiazepine drugs in biological material.
    Tewari SN; Shukla SK
    Pharmazie; 1976; 31(12):893-4. PubMed ID: 1023271
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative analysis of the pharmacokinetics of N1-unsubstituted derivatives of 1,4-benzodiazepine].
    Andronati SA; Golovenko NIa; Stankevich EA; Zin'kovskiĭ VG; Iakubovskaia LN
    Biull Eksp Biol Med; 1986 Feb; 101(2):180-2. PubMed ID: 3947735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1H and 13C NMR identification of unexpected 3,4-dihydroquinoxalines in the syntheses of 1,5-benzodiazepine derivatives.
    Tjiou EM; Lhoussaine EG; Virieux D; Fruchier A
    Magn Reson Chem; 2005 Jul; 43(7):557-62. PubMed ID: 15861489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Definition of a new solvent for solubilizing benzodiazepine].
    Sacchi C
    Boll Chim Farm; 1986 Jan; 125(1):31-4. PubMed ID: 3730176
    [No Abstract]   [Full Text] [Related]  

  • 19. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?
    Almarsson O; Zaworotko MJ
    Chem Commun (Camb); 2004 Sep; (17):1889-96. PubMed ID: 15340589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of liquid chromatography-tandem mass spectrometry (LC-MS/MS) to test blood and urine samples for the toxicological investigation of drug-facilitated crimes.
    Deveaux M; Chèze M; Pépin G
    Ther Drug Monit; 2008 Apr; 30(2):225-8. PubMed ID: 18367985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.